L-lysine pyruvate and l- histidine pyruvate and their use in therapy of tissue and mucosa damage
AssigneeInstitut Dr. Ziegler
InventorWalter J. Ziegler
Life of this patent
Estimating the term…
Abstract
The invention concerns novel pyruvate compounds namely L-lysine pyruvate and L-histidine pyruvate, the method for making these compounds by bringing together pyruvic fluid acid with L-lysine and L-histidine resp., and preparations containing L-lysine pyruvate and/or L-histidine pyruvate.
Claims8
A pyruvic acid selected from the group consisting of L-lysine pyruvate and L-histidine pyruvate.
A composition for prohylaxis and therapy of tissue and mucosa damages comprising a pharmaceutically effective amount of a pyruvic acid derivative selected from the group consisting of L-lysine pyruvate and L-histidine pyruvate and a pharmaceutically acceptable carrier.
A method for prophylaxis and therapy of tissue damage caused by active substances contained in medicaments, food or other ingested materials which cause tissue and mucosa damage which comprises administering a pharmaceutically effective amount of at least one of L-lysine pyruvate and L-histidine pyruvate to a patient requiring such treatment.
Dependencies are inferred from the claim text.